VividFISH™ probe set for CEP17/HER2

User Manual

Product Description

The VividFISH™ CEP17/HER2 probe set detects aberrant amplification of the HER2 gene on chromosome 17 (NCBI GeneID:2064). Amplification of HER2 is associated with poor survival from breast cancer. The VividFISH™ CEP17/HER2 probe set, which is a combination of one probe detecting the HER2 gene and a second control probe detecting the centromere of chromosome 17, provides a valuable tool for determining the prognosis of breast cancer and guiding subsequent treatment regimens.

Vividfish Cep17 Her2 E1458850795182

Pretreatment of FFPE samples can be performed with GeneCopoeias VividFISH™ FFPE-pretreatment Kit.

  • Price
  • 761,00 €
Add to Cart
you need any help?

Please contact:

Dr. Monika Haas

Tel. +49 (0) 6221 71415 16 info@biocat.com